Fourth Dose of COVID-19 Vaccines is Available

South Korea became the latest country to begin administration of the fourth shot of COVID vaccines for people at high-risk last week.

Fourth dose of a COVID-19 vaccine is considered to be approved by the US Food and Drug Administration (FDA) later in the year, as per the Wall Street Journal.

Citing people familiar with the matter, the report claimed that the health regulatory body has begun reviewing data that could lead to clearing a second booster dose of the Pfizer, Moderna vaccines by September.

Covaxin to be Evaluated as COVID-19 Vaccine in US, Say Sources
Covaxin, India's COVID-19 vaccine, is to be evaluated as a vaccine candidate in the United States, said Bharat Biotech.

‘South Korea became the latest country to begin administration of the fourth shot of COVID vaccines for people at high-risk last week. ’

However, the planning is still in the early stages. The authorization will also depend on ongoing studies establishing that a fourth dose would increase people's molecular defenses that waned after their first booster and reduce their risk of symptomatic and severe disease, the report said.

The FDA did not comment on the matter.

But, the agency last month cut short the duration to get a booster dose of COVID-19 vaccines from Pfizer and BioNTech as well as from Moderna, in a bid to provide better protection sooner against the Omicron variant.

Over 175 Crore COVID-19 Vaccines Administered
A new milestone of administering over 175 crore COVID-19 vaccine doses has been achieved by India. India's Covid-19 vaccination coverage has exceeded 175.03 crore.

Israel became the first country, in late December last year, to begin the rollout of a second booster dose to people over-60s, healthcare workers, and those with weakened immune systems.

The US has already approved the fourth dose for immunocompromised people, such as those living with HIV or certain transplant recipients. Other countries that have approved the fourth shot include the UK, Chile.

Three Shots of Pfizer�BioNTech Vaccine Better Than Two
Pfizer–BioNTech COVID-19 vaccine effectiveness against infection, hospitalization, and death up to 8 months after vaccination was assessed in a new study.

Israel is now considering the fourth dose for all adults, above the age of 18, in the wake of a surge in infections driven by the Omicron variant.

South Korea became the latest country, last week, to begin administering the fourth shots of COVID vaccines for people at high risk. However, the country's health regulators do not have plans to expand the fourth dose to all adults.

Indian Government Spends Rs. 250 Crore on Covid-19 Vaccine Research
Union Health Minister Mansukh Mandaviya said that the Central government has spent Rs. 250 crore on developing Covid-19 vaccine research.

Sweden's Health Agency also, last week, recommended people aged 80 or above should receive a fourth jab to ward off waning immunity amid the rampant spread of the Omicron variant.

Several European countries including Hungary and Denmark have also considered rolling out the second booster dose in the wake of the vaccine evading the Omicron variant.

Source-IANS